valproic acid has been researched along with cholecalciferol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ichikawa, Y; Nakano, M; Ohnishi, J; Tomita, S | 1 |
| Borowicz, KK; Czuczwar, SJ; Furmanek-Karwowska, K; Luszczki, JJ; Morawska, M | 1 |
| Bachleda, P; Bitman, M; Doricakova, A; Dvorak, Z; Novotna, A; Pavek, P; Vrzal, R | 1 |
| Doering, L; Howaldt, HP; Khatri, R; Linn, T; Petry, SF; Sauer, H | 1 |
| Kato, Y; Koike, M; Kume, S; Leo, S; Shiraki, N; Tsuchiya, K; Wu, Y; Yokota, M; Yui, S | 1 |
1 review(s) available for valproic acid and cholecalciferol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
6 other study(ies) available for valproic acid and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systems.
Topics: Animals; Biotransformation; Cholecalciferol; Cholestanetriol 26-Monooxygenase; Cytochrome P-450 Enzyme System; Ferredoxin-NADP Reductase; Ferredoxins; Isoenzymes; Kinetics; Male; Microsomes, Liver; Mitochondria, Liver; NADPH-Ferrihemoprotein Reductase; Phenytoin; Rabbits; Steroid Hydroxylases; Valproic Acid | 1991 |
Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock.
Topics: Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Cholecalciferol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Injections, Intraperitoneal; Male; Mental Recall; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Valproic Acid; Vitamins | 2007 |
Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
Topics: Anticonvulsants; Blotting, Western; Cholecalciferol; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Hepatocytes; Histone Deacetylase 1; Humans; Luciferases; Osteomalacia; Plasmids; Pregnane X Receptor; Receptors, Calcitriol; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid Hydroxylases; Transfection; Valproic Acid; Vitamin D3 24-Hydroxylase | 2011 |
Regulation of somatostatin expression by vitamin D3 and valproic acid in human adipose-derived mesenchymal stem cells.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Adipogenesis; Adipose Tissue; Cell Differentiation; Cells, Cultured; Cholecalciferol; Gene Expression Regulation; Humans; Mesenchymal Stem Cells; Osteogenesis; Receptors, Calcitriol; RNA, Messenger; Somatostatin; Valproic Acid; Vitamin D3 24-Hydroxylase | 2019 |
The Effect of Vitamin D3 and Valproic Acid on the Maturation of Human-Induced Pluripotent Stem Cell-Derived Enterocyte-Like Cells.
Topics: Cells, Cultured; Cholecalciferol; Enterocytes; Humans; Induced Pluripotent Stem Cells; Valproic Acid | 2023 |